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Lantibiotic Reductase LtnJ Substrate Selectivity Assessed with a
Collection of Nisin Derivatives as Substrates
Dongdong Mu,a Manuel Montalbán-López,a Jingjing Deng,a Oscar P. Kuipersa,b
Department of Molecular Genetics, University of Groningen, Groningen, The Netherlandsa; The Kluyver Centre for Genomics of Industrial Fermentation, Groningen-Delft,
The Netherlandsb
Lantibiotics are potent antimicrobial peptides characterized by the presence of dehydrated amino acids, dehydroalanine and
dehydrobutyrine, and (methyl)lanthionine rings. In addition to these posttranslational modifications, some lantibiotics exhibit
additional modifications that usually confer increased biological activity or stability on the peptide. LtnJ is a reductase responsi-
ble for the introduction of D-alanine in the lantibiotic lacticin 3147. The conversion of L-serine into D-alanine requires dehydro-
alanine as the substrate, which is produced in vivo by the dehydration of serine by a lantibiotic dehydratase, i.e., LanB or LanM.
In this work, we probe the substrate specificity of LtnJ using a system that combines the nisin modificationmachinery (dehydra-
tase, cyclase, and transporter) and the stereospecific reductase LtnJ in Lactococcus lactis. We also describe an improvement in
the production yield of this system by inserting a putative attenuator from the nisin biosynthesis gene cluster in front of the ltnJ
gene. In order to clarify the sequence selectivity of LtnJ, peptides composed of truncated nisin and different mutated C-terminal
tails were designed and coexpressed with LtnJ and the nisin biosynthetic machinery. In these tails, serine was flanked by diverse
amino acids to determine the influence of the surrounding residues in the reaction. LtnJ successfully hydrogenated peptides
when hydrophobic residues (Leu, Ile, Phe, and Ala) were flanking the intermediate dehydroalanine, while those in which dehy-
droalanine was flanked by one or two polar residues (Ser, Thr, Glu, Lys, and Asn) or Gly were either less prone to be modified by
LtnJ or not modified at all. Moreover, our results showed that dehydrobutyrine cannot serve as a substrate for LtnJ.
Since the discovery of penicillin by Alexander Fleming in 1928,antibiotics have saved the lives of countless people. Regretta-
bly, due to abuse and overuse, increasing resistance to antibiotics
has been found among pathogenic bacteria, which has led to an
urgent need for new antimicrobial compounds (1–4). Lanthipep-
tides, defined as posttranslationally modified peptides containing
a lanthionine and/or methyllanthionine ring(s), are a type of ri-
bosomal peptides produced by many Gram-positive bacteria (5,
6). They can be subdivided into 4 different classes based on the
enzyme(s) that catalyze(s) the formation of lanthionine residues
(6). Some of them (i.e., classes I and II) show antimicrobial activ-
ity and are referred to as lantibiotics (7).
The capability of lantibiotics to inhibit the growth of obsti-
nate pathogens, including multidrug-resistant bacteria such as
methicillin-resistant Staphylococcus aureus, vancomycin-resis-
tant enterococci, and oxacillin-resistant Gram-positive organ-
isms, makes them very promising candidates for future antimicro-
bial development (7–9). So far, only a few lantibiotics have been
commercially applied or are under development for medical use
in spite of their promising properties (7, 10). Nisin, the model
class I lantibiotic produced by the Gram-positive bacterium Lac-
tococcus lactis, has been applied in industry as a food preservative
for decades without triggering effective resistance in pathogens
(11, 12); duramycin, a class II lantibiotic, is in phase II clinical
trials and was proven to be safe and effective for the symptomatic
treatment of cystic fibrosis by inhalation (13). Another class II
lantibiotic, deoxyactagardine B (NVB302; Novacta Biosystems
Limited), is undergoing a phase I clinical trial as a drug candidate
for the treatment of Clostridium difficile infections (14). Further-
more, recent research has shown that some class III lanthipeptides
have unexpected bioactivity to relieve neuropathic pain (15) and
as antiviral compounds (16).
Besides the common (methyl)lanthionine, more than 15 extra
structures have been unveiled in lanthipeptides playing a signifi-
cant role in antimicrobial activity, resistance against proteases,
and/or physicochemical resistance (12, 17–20). For instance, D-al-
anine was found within two lantibiotics: lactocin S and the two-
component lantibiotic lacticin 3147 (Fig. 1) (21–23). According to
the work of Cotter and his coworkers, the replacements of D-ala-
nine by other residues (L-alanine, L-threonine, glycine, and L-va-
line) in lacticin 3147 caused a dramatic decrease in activity against L.
lactis HP (24). Additionally, a gene designated ltnJ was predicted
to encode a protein with significant similarity to zinc-dependent
alcohol dehydrogenases and NAD(P)H-dependent quinone oxi-
doreductases of the zinc-containing alcohol dehydrogenase su-
perfamily (24). LtnJ was shown to be responsible for the forma-
tion of D-alanines in lacticin 3147 with dehydroalanine (Dha) as
an intermediate (24). This dehydroalanine reductase activity to
generate D-alanine has been observed among some homologues of
LtnJ, like SacJ from S. aureus C55 and PenN from Pediococcus
pentosaceus FBB61 (25). In fact, D-alanine in lacticin 3147 can be
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formed by some homologues of LtnJ, although low efficiency was
observed compared to LtnJ (25).
It has been shown that the nisin biosynthetic machinery pos-
sesses high substrate tolerance and can modify diverse peptides
fused to the nisin leader peptide, not only those related to lanthi-
peptides but also unrelated peptide sequences (26–30). Previ-
ously, we successfully introduced D-alanine into nisin by express-
ing LtnJ together with the nisin biosynthetic machinery in a
dual-plasmid system inL. lactis (18). The Dha at position 5 of nisin
has been demonstrated to be modified by LtnJ, while the other
Dha, at position 33, is most likely not (18).
In this study, nisin was used as a model peptide to investigate if
the surrounding residues of Dha affect the conversion of Dha into
D-alanine. Therefore, a mutant oligopeptide tail (AAIS26LALTIK)
was fused at the C terminus of truncated nisin [i.e., NisA(23–
34)], generating a peptide designated NisAtail (Fig. 1). Another 18
variants were designed to probe the influence of flanking residues
in the conversion of Dha into D-alanine by LtnJ. We show that the
polar or hydrophobic nature of flanking amino acids in the sub-
strate plays a vital role in this reaction.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Strains and vectors
used in this work are listed in Table 1. L. lactis strains were cultured in M17
medium supplemented with 0.5% glucose (GM17) at 30°C for genetic
manipulation or in a minimal expression medium (MEM) for protein
expression and purification assays (29). Chloramphenicol and/or eryth-
romycin was used at 5 g/ml when necessary.
Molecular cloning. Molecular cloning techniques were performed as
described by Sambrook and Russell (31). Preparation of competent cells
and transformation were performed as described previously (32). Fast
digest restriction enzymes and ligase were supplied by Fermentas and used
according to the manufacturer’s instructions.
Construction of recombinant vectors. Plasmid isolation was per-
formed with the plasmid DNA extraction kit (Roche). The transcriptional
attenuator region between nisA and nisB was amplified from genomic
DNA of L. lactis NZ9700 using primers P-for-nisA-T and P-rev-nisA-T-
2nd. After digestion using BglII and KpnI, the region was ligated into
pNZ-nisA-ltnJ, which was amplified using the primers P-for-kpnI-ltnJ
and P-rev-bglII-Cmr to insert the KpnI site, resulting in the plasmid pNZ-
nisA-T-ltnJ. Primers P-for-ALTIK and P-rev(01–19) (Table 2) were de-
signed for the construction of the 19 nisin analogues (Table 3; Fig. 1).
Round PCR was performed with pNZ-nisA as the template, primer P-for-
ALTIK as the forward primer, and P-rev(01–19) as the reverse primer to
create 19 different derivatives of pNZ-nisA (Table 1). These resulting
pNZ-nisA derivatives were digested by HindIII and XhoI and ligated with
a fragment containing the transcriptional attenuator and ltnJ to generate
19 different derivatives of pNZ-nisA-T-ltnJ (Table 1). This fragment was
amplified with the primers P-for-HindIII-T-ltnJ and P-ltnJ-rev-XhoI
(Table 2) using pNZ-nisA-T-ltnJ (18). By applying two sets of round PCR
on pNZ-nisA with two pairs of primers, P-for-K34L/P-rev-K34L and
P-for-S29insKIH/P-rev-S29insKIH (Table 2), pNZ-nisin(30 –34)-KI-
HIHVSL was created (Table 1). Similarly, pNZ-nisin(30 –34)-KIHIH-
VSL-T-ltnJ was obtained with pNZ-nisA-T-ltnJ as the template (Table 1).
All the constructs were verified by sequencing.
Protein expression and purification. The pNZ-derivative vectors
containing the mutant structural gene with or without ltnJ were trans-
formed into NZ9000(pIL3EryBTC). The expression assays were per-
FIG 1 Structures of lactocin S, lacticin 3147 (peptides LtnA1 and LtnA2), nisin, nisin with designed C-terminal tail, and nisin(insS29KIH; K34L). The residues
involved in the formation of (methyl)lanthionine are in yellow, D-alanines are depicted in blue, and Dha and Dhb are colored green and purple, respectively. The
pathway for D-alanine conversion from serine is depicted. 2-ob, 2-oxobutyryl group.
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formed as described previously (29). Briefly, MEM was inoculated at 2%
from an overnight culture of the producer strain grown in GM17.
When the fresh culture reached an optical density (OD; 600 nm) of 0.4
to 0.6, nisin was added at a final concentration of 5 ng/ml. Cells were
harvested after 2 h of induction by centrifugation at 4°C for 10 min at
5,000 rpm, and the supernatant was kept for the isolation of the pep-
tides. The cell-free supernatant was mixed at a 1:1 ratio with a 100 mM
lactic acid solution and applied to a 5-ml HiTrap SP-Sepharose (GE
Healthcare) column for cationic exchange chromatography. Bound
peptides were washed with 50 mM lactic acid (pH 4.0) and eluted with
50 mM lactic acid, 1 M NaCl, pH 4.0. Subsequently, a PD-10 desalting
column (GE Healthcare) was used to desalt the sample according to
the provider’s instructions. The production was evaluated by Tricine-
SDS-PAGE as described before (33).
The peptides were purified to homogeneity by reverse-phase high-
performance liquid chromatography (RP-HPLC). A Jupiter 4-m
Proteo 90-Å column, 250 by 4.6 mm (Phenomenex), was used. Sol-
vents for RP-HPLC were solvent A (0.1% trifluoroacetic acid [TFA] in
water) and solvent B (0.1% TFA in acetonitrile). Following a 10-min
washing step with 20% solvent B, a gradient of 27.5 to 47.5% solvent B
over 35 min was executed at a flow rate of 1 ml/min. Peptides were
detected by measuring the absorbance at 205 nm. The production
TABLE 1 Strains and vectors used in this worka
Strain or vector Characteristics Reference
Strains
L. lactis NZ9000 pepN::nisRK; expression host strain 41
L. lactis NZ9700 Nisin-producing transconjugant containing Tn5276; used for cloning of the attenuator 42
Vectors
pIL3EryBTC Eryr nisBTC; modification and transport of lantibiotics 18
pNZ-nisA Cmr nisA; expression of nisin 18
pNZ-nisA-ltnJ Cmr nisA ltnJ; expression of nisin and LtnJ 18
pNZ-nisA-T-ltnJ Derivative of pNZ-nisA-ltnJ; attenuator between nisA and ltnJ This work
pNZ-nisAtail Derivative of pNZ-nisA; nisA; NisAtail This work
pNZ-S26insS Derivative of pNZ-nisA; nisA; S26insS This work
pNZ-S26insSS Derivative of pNZ-nisA; nisA; S26insSS This work
pNZ-S26insT Derivative of pNZ-nisA; nisA; S26insT This work
pNZ-L27K Derivative of pNZ-nisA; nisA; L27K This work
pNZ-I25K Derivative of pNZ-nisA; nisA; I25K This work
pNZ-L27E Derivative of pNZ-nisA; nisA; L27E This work
pNZ-I25E Derivative of pNZ-nisA; nisA; I25E This work
pNZ-L27F Derivative of pNZ-nisA; nisA; L27F This work
pNZ-I25F Derivative of pNZ-nisA; nisA; I25F This work
pNZ-L27N Derivative of pNZ-nisA; nisA; L27N This work
pNZ-I25N Derivative of pNZ-nisA; nisA; I25N This work
pNZ-L27G Derivative of pNZ-nisA; nisA; L27G This work
pNZ-I25G-L27G Derivative of pNZ-nisA; nisA; I25G-L27G This work
pNZ-I25G Derivative of pNZ-nisA; nisA; I25G This work
pNZ-L27A Derivative of pNZ-nisA; nisA; L27A This work
pNZ-I25A-L27A Derivative of pNZ-nisA; nisA; I25A-L27A This work
pNZ-I25A Derivative of pNZ-nisA; nisA; I25A This work
pNZ-S26T Derivative of pNZ-nisA; nisA; S26T This work
pNZ-nisin(30–34)-KIHIHVSL Derivative of pNZ-nisA; nisA; nisin(30–34)-KIHIHVSL This work
pNZ-nisAtail-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; NisAtail This work
pNZ-S26insS-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; S26insS This work
pNZ-S26insSS-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; S26insSS This work
pNZ-S26insT-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; S26insT This work
pNZ-L27K-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; L27K This work
pNZ-I25K-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; I25K This work
pNZ-L27E-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; L27E This work
pNZ-I25E-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; I25E This work
pNZ-L27F-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; L27F This work
pNZ-I25F-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; I25F This work
pNZ-L27N-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; L27N This work
pNZ-I25N-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; I25N This work
pNZ-L27G-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; L27G This work
pNZ-I25G-L27G-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; I25G-L27G This work
pNZ-I25G-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; I25G This work
pNZ-L27A-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; L27A This work
pNZ-I25A-L27A-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; I25A-L27A This work
pNZ-I25A-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; I25A This work
pNZ-S26T-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; S26T This work
pNZ-nisin(30–34)-KIHIHVSL-T-ltnJ Derivative of pNZ-nisA-T-ltnJ; nisA; nisin(30–34)-KIHIHVSL This work
a Cmr, chloramphenicol resistance; Eryr, erythromycin resistance.
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levels of the different mutants were assessed by determining the areas
of the peaks.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
and LC-MS. The PD-10-desalted peptide was digested with 1 l of
1-mg/ml sequencing-grade trypsin in 5 mM CaCl2 and 50 mM Tris (pH
6.8) solution at 37°C for 16 h.
After trypsin digestion, the proteolytic mix was injected into an Ulti-
mate 3000 nano-LC-MS/MS system (Dionex, Amsterdam, The Nether-
lands) in line connected to an LTQ Orbitrap XL mass spectrometer
(Thermo Fisher Scientific, Bremen, Germany). The sample mixture was
loaded on a trapping column (Acclaim PepMap; C18; 5-mm length by
300-m inside diameter [i.d.]; 5-m particle size; 100-Å porosity; Di-
onex) and washed. After 3 min, the mixture was separated using a 42-min
linear gradient from 95% solvent C (0.1% formic acid) to 90% solvent D
(0.1% formic acid in acetonitrile) at a flow rate of 250 nl/min. The mass
spectrometer was operated in data-dependent mode, automatically
switching between MS and MS/MS acquisition for the five most abundant
doubly and triply charged ions with a minimal signal of 2,500 in a given
MS spectrum. Full-scan MS spectra were acquired from m/z 300 to 1,300
in the Orbitrap spectrometer at a target value of 1E6 with a resolution of
60,000. The five most intense ions which met the set criteria were then
isolated for fragmentation in the linear ion trap, with a dynamic exclusion
of 10 s. Peptides were fragmented after filling the ion trap at a target value
of 1E4 ion counts. Data were analyzed using Peak6 software (Bioinfor-
matics Solutions Inc., Waterloo, Ontario, Canada).
The intact peptides were analyzed using the same setup with the fol-
lowing modifications: the column temperature was 50°C, and after a
5-min wash, a 44-min gradient from 10% to 40% of solvent D at a flow
rate of 300 nl/min was performed. The mass range was set to 400 to 1,900
Da. Data were processed using Xtract software (Thermo). Arbitrary abun-
dance of peptide fragments of interest was calculated on the basis of pro-
portional relationship between the area of the chromatographic peak and
the corresponding peptide. The conversion rate of LtnJ was obtained by
dividing the arbitrary abundance of tail peptide containing D-alanine-26
by the summed arbitrary abundance of tail peptides containing D-ala-
nine-26 and Dha26, respectively.
RESULTS
Improvement of the production of nisin and its derivatives.The
production level of nisin decreased 3-fold when coexpressed
with LtnJ using L. lactis NZ9000(pIL3EryBTC, pNZ-nisA-ltnJ) as
a host strain compared to use of the strain L. lactis NZ9000
(pIL3EryBTC, pNZ-nisA) (Fig. 2). An attenuator structure lo-
cated downstream of thenisA gene in the nisin biosynthesis cluster
(11) was cloned into pNZ-nisA-ltnJ between the genes nisA and
ltnJ, resulting in pNZ-nisA-T-ltnJ. This regulatory element en-
sures high transcription of the structural gene but a reduced
transcription level of ltnJ from the nisA promoter. The peptides
produced in the culture supernatant of NZ9000(pIL3EryBTC,
pNZ-nisA), NZ9000(pIL3EryBTC, pNZ-nisA-ltnJ), and NZ9000
TABLE 2 Primers used in this study
Primer Sequencea Characteristic/function
P-for-nisA-T GGAAGATCTAGTCTTATAACTATAC BglII cleavage site
P-rev-nisA-T-2nd CGGGGTACCTGTTTTTTCCTCTC KpnI cleavage site
P-for-KpnI-ltnJ CGGGGTACCCTGTAAGGAGAAAAATTATG KpnI cleavage site
P-rev-BglII-Cmr GGAAGATCTTGGAGCTGTAATATAAAAAC BglII cleavage site




P-for-ALTIK GCGTTAACAATTAAATAAGCTTTCTTTGAACC General forward primer; 5=
phosphorylation
P-rev01 AAGAGATATAGCTGCTTTCATGTTACAACCCATC Construction of NisAtail
P-rev02 AAGAGAAGATATAGCTGCTTTCATGTTACAACCCATC Construction of S26insS
P-rev03 AAGAGAAGAAGATATAGCTGCTTTCATGTTACAACCCATC Construction of S26insSS
P-rev04 AAGTGTAGATATAGCTGCTTTCATGTTACAACCCATC Construction of S26insT
P-rev05 TTTAGATATAGCTGCTTTCATGTTACAACCCATC Construction of L27K
P-rev06 AAGAGATTTAGCTGCTTTCATGTTACAACCCATC Construction of I25K
P-rev07 TTCAGATATAGCTGCTTTCATGTTACAACCCATC Construction of L27E
P-rev08 AAGAGATTCAGCTGCTTTCATGTTACAACCCATC Construction of I25E
P-rev09 AAAAGATATAGCTGCTTTCATGTTACAACCCATC Construction of L27F
P-rev10 AAGAGAAAAAGCTGCTTTCATGTTACAACCCATC Construction of I25F
P-rev11 ATTAGATATAGCTGCTTTCATGTTACAACCCATC Construction of L27N
P-rev12 AAGAGAATTAGCTGCTTTCATGTTACAACCCATC Construction of I25N
P-rev13 ACCAGATATAGCTGCTTTCATGTTACAACCCATC Construction of L27G
P-rev14 ACCAGAACCAGCTGCTTTCATGTTACAACCCATC Construction of I25G-L27G
P-rev15 AAGAGAACCAGCTGCTTTCATGTTACAACCCATC Construction of I25G
P-rev16 TGCAGATATAGCTGCTTTCATGTTACAACCCATC Construction of L27A
P-rev17 TGCAGATGCAGCTGCTTTCATGTTACAACCCATC Construction of I25A-L27A
P-rev18 AAGAGATGCAGCTGCTTTCATGTTACAACCCATC Construction of I25A
P-rev19 AAGTGTTATAGCTGCTTTCATGTTACAACCCATC Construction of S26T
P-for-K34L TTTTAAGCTTTCTTTGAACC Construction of nisin(30–34)-KIHIHVSL
P-rev-K34L GCTTACGTGAATACTACAATG Construction of nisin(30–34)-KIHIHVSL;
5= phosphorylation
P-for-S29insKIH AAAATTCACATTCACGTAAGCTTTTAAGC Construction of nisin(30–34)-KIHIHVSL
P-rev-S29insKIH ACTACAATGACAAGTTGCTG Construction of nisin(30–34)-KIHIHVSL;
5= phosphorylation
a Restriction sites engineered in the primers are underlined.
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(pIL3EryBTC, pNZ-nisA-T-ltnJ) were purified by cationic ex-
change chromatography. Tricine-SDS-PAGE was used to visual-
ize the semipurified peptide. The peptides from the three strains
migrated as a band of approximately 6 kDa, which is in line with
the theoretic mass of the nisin precursor (Fig. 2A). Peptides from
NZ9000(pIL3EryBTC, pNZ-nisA), NZ9000(pIL3EryBTC, pNZ-
nisA-ltnJ), and NZ9000(pIL3EryBTC, pNZ-nisA-T-ltnJ) were
further purified via RP-HPLC. An intense peak with a retention
time of 24.6 min was observed in all the strains (Fig. 2B). The
purified peptide from NZ9000(pIL3EryBTC, pNZ-nisA-T-ltnJ)
was collected for a more accurate characterization by LC-MS. We
could observe a peak corresponding to a peptide with a positive
mass shift of 2 Da compared to the peptide from NZ9000
(pIL3EryBTC, pNZ-nisA), indicating that one Dha was converted
into D-alanine by LtnJ (see Fig. S1 in the supplemental material).
These results are consistent with the previous results when the
attenuator was not present in the construction (18). Comparing
the areas under the curves of the different peaks from nisin and its
TABLE 3 Core peptide sequences of NisA mutant peptidesa







1 NisAtail ITSISLCTPGCKTGALMGCNMKAAISLALTIK 2 (S26, T30)  
2 S26insS ITSISLCTPGCKTGALMGCNMKAAISSLALTIK 3 (S26, S27, T31)  
3 S26insSS ITSISLCTPGCKTGALMGCNMKAAISSSLALTIK 3 (S26, S27, T32)  
4 S26insT ITSISLCTPGCKTGALMGCNMKAAISTLALTIK 3 (S26, T27, T31)  
5 L27K ITSISLCTPGCKTGALMGCNMKAAISKALTIK 2 (S26, T30)  
6 I25K ITSISLCTPGCKTGALMGCNMKAAKSLALTIK 2 (S26, T30)  
7 L27E ITSISLCTPGCKTGALMGCNMKAAISEALTIK 2 (S26, T30)  
8 I25E ITSISLCTPGCKTGALMGCNMKAAESLALTIK 2 (S26, T30)  
9 L27F ITSISLCTPGCKTGALMGCNMKAAISFALTIK 2 (S26, T30)  
10 I25F ITSISLCTPGCKTGALMGCNMKAAFSLALTIK 2 (S26, T30)  
11 L27N ITSISLCTPGCKTGALMGCNMKAAISNALTIK 2 (S26, T30)  
12 I25N ITSISLCTPGCKTGALMGCNMKAANSLALTIK 2 (S26, T30)  
13 L27G ITSISLCTPGCKTGALMGCNMKAAISGALTIK 2 (S26, T30)  
14 I25G-L27G ITSISLCTPGCKTGALMGCNMKAAGSGALTIK 2 (S26, T30)  
15 I25G ITSISLCTPGCKTGALMGCNMKAAGSLALTIK 2 (S26, T30)  
16 L27A ITSISLCTPGCKTGALMGCNMKAAISAALTIK 2 (S26, T30)  
17 I25A-L27A ITSISLCTPGCKTGALMGCNMKAAASAALTIK 2 (S26, T30)  
18 I25A ITSISLCTPGCKTGALMGCNMKAAASLALTIK 2 (S26, T30)  
19 S26T ITSISLCTPGCKTGALMGCNMKAAITLALTIK 2 (T26, T30)  
20 nisin(30–34)-KIHIHVSL ITSISLCTPGCKTGALMGCNMKTATCHCSKIHIHVSL 1 (S36) N.A. N.A.
a C-terminal extensions in nisin are underlined, with the dehydratable residues serine and threonine in bold. The replacements of I25 and L27 flanking serine residues are shaded.
b Symbols:,50%;, 10 to 50%;, no conversion. N.A., not applicable.
FIG 2 (A) Tricine-SDS-PAGE analysis after cationic exchange chromatographic purification of nisin with/without D-alanine. M, molecular mass marker; I,
protein purified from NZ9000(pIL3EryBTC, pNZ-nisA); II, protein purified from NZ9000(pIL3EryBTC, pNZ-nisA-ltnJ); III, protein purified from
NZ9000(pIL3EryBTC, pNZ-nisA-T-ltnJ). (B) HPLC profile of nisin with/without D-alanine. Blue, protein purified from NZ9000(pIL3EryBTC, pNZ-nisA); red,
protein purified from NZ9000(pIL3EryBTC, pNZ-nisA-ltnJ); green, protein purified from NZ9000(pIL3EryBTC, pNZ-nisA-T-ltnJ).
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derivatives on the HPLC profile, we observed that the level of nisin
produced by NZ9000(pIL3EryBTC, pNZ-nisA-T-ltnJ) was 2-fold
higher than that of NZ9000(pIL3EryBTC, pNZ-nisA-ltnJ), al-
though it was still lower than the level of nisin without the addi-
tion of LtnJ to the system (Fig. 2B).
LtnJ can modify the C terminus of peptides. D-Alanine has
been observed at the N-terminal part of the two peptides, LtnA1
and LtnA2, that compose lacticin 3147 (22). Recently, van Heel et
al. showed that when LtnJ was expressed with the nisin machinery,
the Dha at position 5 in nisin could be modified into D-alanine
while Dha at position 33 was most likely unmodified (18). To
investigate if the function of LtnJ is position dependent, plasmids
pNZ-NisAtail and pNZ-NisAtail-T-ltnJ, producing mutants of
nisin in the absence or presence of LtnJ, respectively, were con-
structed (Table 1). In these mutants, the C-terminal region of
nisin (residues 23 to 34) was replaced by a linear peptide sequence
(AAIS26LALTIK) (Table 3) containing a serine that could be de-
hydrated more effectively than Ser33 in nisin (34). Additionally,
the lack of cysteine residues in this fragment (and therefore the
absence of lanthionine rings) facilitates MS/MS fragmentation
and characterization. Peptides purified by cationic exchange chro-
matography from both NZ9000(pIL3EryBTC, pNZ-NisAtail) and
NZ9000(pIL3EryBTC, pNZ-NisAtail-T-ltnJ) were digested by
trypsin and analyzed by LC-MS/MS. The conversion of Dha to
D-alanine was detected only in the case of NZ9000(pIL3EryBTC,
pNZ-NisAtail-T-ltnJ) compared to the control strain NZ9000
(pIL3EryBTC, pNZ-NisAtail), as expected (Fig. 3). De novo se-
quencing data for the C terminus of NisAtail obtained following
trypsin digestion showed that when LtnJ was expressed, 70% of
Dha26 was hydrogenated into D-alanine in the fully dehydrated
peptide. This percentage is 57% for peptides where Thr30 was not
dehydrated (Fig. 4). Our results prove that LtnJ can modify Dha
when it is located at the C-terminal part of the precursor peptide.
Flanking residues of the substrate Dha affect the modifica-
tion by LtnJ. To explore the role of flanking residues of Dha dur-
ing biosynthesis, 17 nisin mutant peptides (peptides 2 to 18) (Fig.
1; Table 3) were designed and constructed similarly to the mutant
NisAtail described above. Thus, we replaced the C terminus of
nisin with a peptide sequence (AAIS26LALTIK) in which flanking
amino acids of Ser26 (i.e., I25 and L27) were mutated into serine,
threonine, lysine, glutamic acid, phenylalanine, asparagine, gly-
cine, or alanine (Table 3). The modification extent of this poly-
peptide tail in nisin was thoroughly studied by LC-MS/MS for all
these mutants. According to the LC-MS/MS profile, conversion
into D-alanine from Ser26 was observed in L27F, I25F, L27N,
L27A, I25A-L27A, and I25A (Table 3; see also Fig. S2 to S7 in the
supplemental material). The conversion rate of Dha into D-ala-
nine is 71% (L27F), 67% (I25F), 13% (L27N), 54% (L27A), and
71% (I25A) compared to the fully dehydrated peptide (Fig. 4; see
also Fig. S3 in the supplemental material). In the cases where the
threonine at position 30 is not dehydrated, the conversion of Dha
into D-alanine is not detected for L27F or I25F, is hardly detected
for L27N, and drops to 13% for L27A and 35% for I25A (Fig. 4; see
also Fig. S8 in the supplemental material for L27A). An exception
is that I25A-L27A was modified by LtnJ only when threonine was
not dehydrated with a conversion rate of 16%.
In mutant peptides (peptides 2 to 8 and 13 to 15) where Ser26
was neighbored by small polar amino acids (Ser/Thr), charged
residues (Lys/Glu), or glycine, hydrogenation was not detected
(Table 3), although serine was dehydrated in all cases. A similar
result is obtained when asparagine is present at the N terminus of
Ser26. On the other hand, a relatively low rate of conversion by
LtnJ was detected when asparagine was located C terminally to
Ser26 (Table 3; Fig. 4). The presence of charges, either positive or
negative, did not allow the conversion into D-alanine in spite of
Dha being present. Similarly, the presence of dehydrated residues
Dha and dehydrobutyrine (Dhb) inhibited the hydrogenation of
the adjacent Dha (Table 3).
In order to study the modification of Ser33 in nisin, a mutant
nisin(30 –34)-KIHIHVSL (Table 3; Fig. 1) was designed in
which the last residue, Lys34, was mutated into Leu to favor the
dehydration by NisB and a Lys-Ile-His sequence was inserted
downstream of Ser29, offering a cleavage site for trypsin digestion.
A mass shift of 2 Da was not observed when LtnJ was coexpressed
with nisin(30 –34)-KIHIHVSL (Table 3).
Dhb isnot a substrate forLtnJ.The mutant S26T was designed
to mimic the conditions in which Dha is converted into D-alanine
and therefore provide optimal conditions under which to investi-
gate the conversion of Dhb into D-aminobutyrate (Table 3). Al-
though threonines at positions 26 and 30 were dehydrated by
NisB, providing a possible substrate for LtnJ (i.e., Dhb), D-ami-
nobutyrate was not detected in any case (Table 3). This result
indicated that the additional methyl group in Dhb prevents the
hydrogenation catalyzed by LtnJ.
DISCUSSION
The combination of different posttranslational modification en-
zymes in peptide design and production is a promising approach
(35). The success of these efforts depends to a great extent on the
correct characterization of the enzymes that can be used (e.g.,
dependence on leader peptide recognition, cofactors, target se-
quence, substrate tolerance, etc.). In a previous study, we demon-
strated that the modification machinery of nisin can be expanded
with additional posttranslational modification enzymes, in this
case, LtnJ and GdmD, which do not require their original leader
peptide sequence for target recognition (18). However, we ob-
served a reduced production of nisin in the presence of LtnJ (18).
Therefore, we attempted to improve the production of the struc-
tural peptide. In diverse lantibiotic operons and other bacteriocin
systems, an inverted repeat sequence is observed between the
structural gene and the next open reading frame (ORF) within the
same operon (36–38). By introducing an attenuator between nisA
and ltnJ in our plug-and-play production system (18), the produc-
tion level of the structural gene was improved more than 2-fold.
These sequences may act as processing sites for the mRNA or as
transcriptional attenuators which, in either case, ensure an appro-
priate ratio of enzymes and structural peptide. Additionally, the
inverted repeats can affect the stability of the transcript as in the
case of enterocin AS-48 (38) or Pep5 (39).
At present, an impressive number of different posttranslational
modifications have been unveiled in lantibiotics (20). For example,
aminovinyl-cysteine in gallidermin and epidermin, lysinoalanine in
cinnamycin, or N-terminal lactate formation in epilancin 15X in-
creases the biological activity and/or constrains the structure of the
lantibiotics in which it naturally appears. D-Alanine, present in lacti-
cin 3147, is one of the modifications that has been further investi-
gated. Previous studies demonstrated the importance of D-alanine for
the activity of lacticin 3147 and identified LtnJ as the responsible
reductase producing D-alanine by deletion-complementation exper-
iments (24). As reported previously, when LtnJ is coexpressed with
Mu et al.
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the model lantibiotic nisin, Dha33 within nisin is likely not modified
by LtnJ, whereas Dha5 is partially reduced by LtnJ to form D-alanine
(18). In the same article, the hypothesis that amino acids flanking Dha
may affect the function of LtnJ was raised. In order to clarify the
specificity of LtnJ and to extend the applicability of this enzyme as a
general tool for the designed modification of peptides, its selectivity
was investigated in this study. For this purpose, we designed a set of
mutants of nisin where the C terminus was replaced by a linear poly-
peptide tail (AAIS26LALTIK) that facilitates de novo sequencing by
LC-MS/MS due to the absence of lanthionine rings in this region. In
this tail, the substrate Dha (i.e., Ser26) is flanked by different residues.
In our experiment, the serine in position 26 was dehydrated by NisB
in all cases, rendering Dha26 (Dha27 for S26insS and S26insSS).
However, only in some specific cases, Dha26 was converted into the
FIG 3 MS/MS spectra of C-terminal tryptic fragment of NisAtail when LtnJ was present, showing the occurrence of D-alanine conversion. Expected masses for
y and b ions are listed above and below the peptide sequence, respectively. Ions that were positively identified in the MS/MS spectrum are highlighted in blue (b
ions) or red (y ions). D-Alanine converted from serine is colored blue; threonine and dehydrated threonine are labeled in purple and green, respectively. (A) Partly
dehydrated peptide; (B) fully dehydrated peptide.
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hydrogenated form D-alanine. The high ratio of hydrogenated pep-
tide compared to the corresponding mutant in NisAtail, L27F, I25F,
L27A, and I25A emphasizes the importance of hydrophobic residues
flanking the intermediate Dha for the function of LtnJ. The conver-
sion observed in L27N (although in small amounts) and not detect-
able in I25N indicates a clear preference for an N-terminal hydropho-
bic residue flanking Dha. This phenomenon suggests that the active
site in LtnJ is most likely surrounded by nonpolar residues. Addition-
ally, the presence of D-alanine at the C terminus of the designed mu-
tants demonstrates that the activity of LtnJ is not restricted to the
N-terminal part of the peptide, although in its natural substrates D-
alanine occurs only in that part of the peptide (Fig. 1). Recently pub-
lished research showed that the reductase CrnJ fromCarnobacterium
maltaromaticum C2 could modify dehydroamino acids into D-
amino acids at very different locations in the core peptide of car-
nolysin (40). Whether LtnJ can do so as well remains to be proved.
The failure of modification by LtnJ in the tail of nisin(30 –34)-
KIHIHVSL was probably due to the negative charge of the car-
boxyl group of the C-terminal leucine.
In both peptide LtnA1 and peptide LtnA2, the natural sub-
strates of LtnJ, there are Dhb residues that are not converted into
a reduced form (24). This is also the case for lactocin S (21). In
order to determine whether this effect is caused by the different
location and flanking residues or whether Dhb cannot serve as a
substrate for LtnJ at all, we engineered a mutant where Dha was
replaced by Dhb at the same location and surrounded by the same
environment. Our data also exclude Dhb as a substrate for LtnJ
and indicate that LtnJ is a Dha-specific hydrogenase, as previously
suggested (24). Nevertheless, the reductase CrnJ from the carno-
lysin gene cluster can reduce Dhb flanked by hydrophobic amino
acids and render D-aminobutyrate, which points at a broader sub-
strate tolerance for CrnJ than for LtnJ (40).
An interesting observation is that among these modified mu-
tants (NisAtail, L27F, I25F, L27A, I25A-L27A, and I25A) where
Ser26 was flanked by hydrophobic amino acids, LtnJ preferred to
modify Dha with a larger residue (Leu and Phe) on its C-terminal
side rather than a smaller one (Ala).
In this study, we shed light on the specificity of LtnJ in terms of
peptide sequence. We show the promiscuity of this leader-inde-
pendent reductase when hydrophobic residues are neighboring
Dha, which is its only substrate, as Dhb is never found to be mod-
ified by LtnJ. We also show that the reductase action can also take
place at the C-terminal region of lantibiotics, although this has not
been found in nature. Our data provide a deeper insight into the
use of LtnJ as a tool to engineer designed peptides in future re-
search.
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